The Etiology of Bloodstream Infections at an Italian Pediatric Tertiary Care Hospital: A 17-Year-Long Series
-
Published:2024-08-09
Issue:8
Volume:13
Page:675
-
ISSN:2076-0817
-
Container-title:Pathogens
-
language:en
-
Short-container-title:Pathogens
Author:
Russo Chiara12, Mariani Marcello2ORCID, Bavastro Martina34, Mesini Alessio2ORCID, Saffioti Carolina2ORCID, Ricci Erica2, Ugolotti Elisabetta5, Bandettini Roberto5, Castagnola Elio2ORCID
Affiliation:
1. Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Sciences (DiNOGMI), University of Genoa, 16132 Genoa, Italy 2. Infectious Diseases Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy 3. Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy 4. Infectious Diseases Unit, IRCCS Ospedale Policlinico San Martino, 16147 Genoa, Italy 5. Laboratory of Microbiology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy
Abstract
Knowledge of epidemiology is essential for guiding correct antibiotic prescription, reducing bacteremia-associated mortality, and implementing targeted infection control programs. However, only a few studies have reported on the epidemiology of bloodstream infections (BSIs) in pediatrics. We performed a retrospective analysis of all BSIs (excluding those caused by common skin contaminants) diagnosed from 2006 to 2022 in patients younger than 18 years who were treated at an Italian pediatric tertiary care hospital. Overall, 2395 BSIs were recorded, including 2207 (92.15%) due to bacteria and 188 (7.85%) due to fungi. The incidence rate (BSIs/10,000 hospital discharges, IR) of bacterial BSIs significantly increased during the study period. In particular, BSIs caused by S. aureus (including MRSA), Enterobacterales (including ESBL and AmpC producers), Enterococcus spp., and P. aeruginosa became more common. The frequency of carbapenem-resistant strains was <1% and stable over time. Conversely, there was a significant reduction in the incidence of BSIs due to S. pneumoniae. The BSIs were stratified by patient age, and S. aureus was the most frequent cause of BSIs in all age groups, while E. coli was the most frequent in the Enterobacterales family. S. agalactiae was the third most frequent cause of neonatal early-onset BSIs. The prevalence of Enterococcus spp. increased in the subgroups from 8 days to 5 years of age, while P. aeruginosa became more prevalent in children over 5 years of age. S. aureus was also the most frequent isolate in both community- and hospital-onset BSIs, followed by E. coli. The prevalence of multidrug-resistant (MDR) pathogens was very low. It was <5% for both Gram-positive (i.e., MRSA and VRE) and Gram-negative (ESBL, AmpC, and carbapenem-resistant) pathogens, and MDR pathogens were almost exclusively detected in hospital-onset BSIs. Fungi accounted for just under 8% of BSIs. C. albicans was the most frequently isolated strain, followed by C. parapsilosis. Notably, the IR of fungemia did not change significantly during the study period, in spite of an increase in the absolute number of events. The continuous monitoring of local epidemiology is essential to identify changes in the IRs of pathogens and antibiotic susceptibility and to guide antibiotic treatments, especially in the phase when antibiograms are not yet available.
Funder
Italian Ministry of Health—Ricerca Corrente 2023 IRCCS Istituto Giannina Gaslini
Reference36 articles.
1. International Consensus Criteria for Pediatric Sepsis and Septic Shock;Schlapbach;JAMA,2024 2. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children;Weiss;Pediatr. Crit. Care Med.,2020 3. Romandini, A., Pani, A., Schenardi, P.A., Pattarino, G.A.C., De Giacomo, C., and Scaglione, F. (2021). Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future. Antibiotics, 10. 4. Yu, D., Zheng, Y., Shen, A., Wu, F., Dmitriev, A.V., Kilian, M., and Yang, Y. (2023). Editorial: Antimicrobial resistance in pediatric infectious diseases: Antimicrobial resistance, resistance mechanisms and antimicrobial use. Front. Cell. Infect. Microbiol., 13. 5. Empiric antimicrobial therapy in the intensive care unit based on the risk of multidrug-resistant bacterial infection: A single-centre case-control study of blood culture results in Japan;Nanao;Antimicrob. Resist. Infect. Control,2023
|
|